In breast cancer, MSCs potentiate stemness by inducing microRNA-199a and microRNA-214 expression in cancer cells, which have been shown to repress Forkhead box protein P2 (FOXP2) expression and thus enhance mammary CSC features. This evidence concerns the gene FOXP2 and cancer.